Luvo Health vs Synergy Rx
Two GLP-1 desks, one scoreboard. We put Luvo Health and Synergy Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
Luvo Health
The verdict
Luvo Health takes this head-to-head.
Luvo Health scores 79 to 67 on our six-factor Brief Score — A longevity-leaning telehealth brand ("Longevity-focused care for real life") that publishes a full 4/12/24/52-week term ladder for compounded semaglutide and tirzepatide, plus a real brand-name Ozempic route and a separate NAD+/Sermorelin longevity line — all static pricing, no quiz.
That doesn't make Synergy Rx a bad call — it's best for readers who want to verify who is actually prescribing and compounding their medication, and who will read past the first-month rate to the $249 or $399 they will pay from month two. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Luvo Health | Synergy Rx | |
|---|---|---|
| Brief Score | 79/100 (C) | 67/100 (C) |
| Semaglutide | $249/4-wk injection or $279/4-wk tablets — as low as $45/wk (injection), but only on a prepaid 52-wk term | $249/mo ongoing, compounded ($199 first month only) + an $80 visit fee charged whether or not you get medication |
| Tirzepatide | $339/4-wk term — as low as $67/wk, but only on a prepaid 52-wk term | $399/mo ongoing, compounded ($349 first month only); the ODT bundles price HIGHER, at $399.67–$399.92/mo |
| Coverage | Not disclosed | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
Luvo Health: 4-week entry prices unchanged from our last reading ($249 semaglutide injection / $339 tirzepatide), but this pass confirmed the full term ladder: both molecules get progressively cheaper per week on 12-, 24- and 52-week prepaid terms, down to $45/wk and $67/wk respectively — real savings, in exchange for a real lump-sum commitment.
Synergy Rx: First reading, 7 August 2026. Ongoing month-to-month is $249 semaglutide and $399 tirzepatide; the $199 and $349 figures carried in older datasets are first-month-only rates. An $80 telehealth visit fee sits outside every headline and is charged whether or not medication is dispensed.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.